Panjon Balance Sheet Annual

BSE: 526345 | NSE: - | ISIN: INE744D01019 | Sector: Biotechnology & Drugs

22.20 +0.11 (0.50%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	2.72	1.47	1.44	0.31
Short Term Investments	0.04	0.03	0.07	0.01
Cashand Short Term Investments	2.76	1.50	1.50	0.32
Accounts Receivable- Trade Net	1.81	1.56	0.61	3.71
Total Receivables Net	6.06	5.66	3.65	7.86
Total Inventory	3.74	3.48	3.77	3.87
Total Current Assets	12.56	10.64	8.92	12.05
Property/ Plant/ Equipment Total- Net	0.89	0.90	0.94	0.95
Intangibles Net	0.01	0.01	0.01	0.01
Long Term Investments	1.08	1.08	1.07	1.07
Note Receivable- Long Term	1.29	1.07	2.63	4.57
Other Long Term Assets Total	1.56	1.19	0.48	0.60
Total Assets	17.39	14.90	14.05	19.25
Accounts Payable	0.17	0.36	0.24	0.91
Notes Payable/ Short Term Debt	1.30	0.52	0.31	0.05
Other Currentliabilities Total	0.93	0.28	0.34	0.21
Total Current Liabilities	2.40	1.16	1.08	1.37
Long Term Debt	0.14	0.00	0.08	0.86
Total Long Term Debt	0.14	0.26	0.30	1.07
Total Debt	1.44	0.78	0.81	1.32
Total Liabilities	2.54	1.42	1.38	2.44
Common Stock Total	16.31	15.50	15.50	15.50
Other Equity Total	-1.46	-2.02	-2.84	1.31
Total Equity	14.85	13.48	12.66	16.81
Total Liabilities Shareholders' Equity	17.39	14.90	14.05	19.25
Total Common Shares Outstanding	1.63	1.55	1.55	1.55
Tangible Book Valueper Share Common Eq	9.10	8.69	8.16	10.84
Capital Lease Obligations	-	0.26	0.22	0.21
Other Liabilities Total	-	0.00	0.00	0.00
Current Portof LT Debt/ Capital Leases	-	-	0.20	0.20